Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NNDM
2276
Nano Dimension
NNDM
$328M
| $1.44M | ﹤0.01% |
579,600
+497,600
| +607% | +$1.15M |
|
2277
Verra Mobility
VRRM
$761M
| $1.44M | ﹤0.01% |
+59,400
| New | +$1.47M |
|
2278
Orthofix Medical
OFIX
$428M
| $1.44M | ﹤0.01% |
82,190
+51,399
| +167% | +$894K |
|
2279
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $1.43M | ﹤0.01% |
+30,000
| New | +$1.51M |
|
2280
Crexendo
CXDO
$215M
| $1.43M | ﹤0.01% |
274,100
+38,700
| +16% | +$205K |
|
2281
Sight Sciences
SGHT
$386M
| $1.43M | ﹤0.01% |
393,006
+340,906
| +654% | +$1.55M |
|
2282
GoPro
GPRO
$127M
| $1.43M | ﹤0.01% |
1,310,400
+164,600
| +14% | +$209K |
|
2283
KVH Industries
KVHI
$163M
| $1.42M | ﹤0.01% |
249,915
+48,002
| +24% | +$247K |
|
2284
Stoke Therapeutics
STOK
$2.06B
| $1.42M | ﹤0.01% |
+129,043
| New | +$1.59M |
|
2285
Domo
DOMO
$179M
| $1.42M | ﹤0.01% |
200,980
-21,655
| -10% | -$175K |
|
2286
Embecta
EMBC
$209M
| $1.42M | ﹤0.01% |
68,848
+23,748
| +53% | +$389K |
|
2287
iShares MSCI World ETF
URTH
$8.21B
| $1.42M | ﹤0.01% |
9,100
+6,000
| +194% | +$949K |
|
2288
Five Point Holdings
FPH
$372M
| $1.41M | ﹤0.01% |
373,900
-117,200
| -24% | -$459K |
|
2289
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.79B
| $1.41M | ﹤0.01% |
11,300
-300
| -3% | -$38.4K |
|
2290
Flexible Solutions
FSI
$63.5M
| $1.41M | ﹤0.01% |
389,445
+20,000
| +5% | +$76.3K |
|
2291
Kaltura
KLTR
$269M
| $1.4M | ﹤0.01% |
638,600
+235,200
| +58% | +$429K |
|
2292
CB Financial Services
CBFV
$191M
| $1.4M | ﹤0.01% |
49,099
-2,800
| -5% | -$82.7K |
|
2293
Biglari Holdings Class B
BH
$1.22B
| $1.4M | ﹤0.01% |
5,516
+3,040
| +123% | +$612K |
|
2294
Digimarc Corp
DMRC
$165M
| $1.4M | ﹤0.01% |
37,400
+15,900
| +74% | +$519K |
|
2295
Acushnet Holdings
GOLF
$5.64B
| $1.4M | ﹤0.01% |
19,693
+9,493
| +93% | +$645K |
|
2296
Mistras Group
MG
$493M
| $1.4M | ﹤0.01% |
154,500
-21,700
| -12% | -$214K |
|
|
VOXR
2297
Vox Royalty Corp
VOXR
$342M
| $1.4M | ﹤0.01% |
596,472
+29,172
| +5% | +$80K |
|
2298
Data I/O
DAIO
$31.3M
| $1.4M | ﹤0.01% |
503,643
+3,654
| +0.7% | +$9.58K |
|
2299
CytomX Therapeutics
CTMX
$734M
| $1.39M | ﹤0.01% |
1,346,800
+331,800
| +33% | +$357K |
|
2300
NI Holdings
NODK
$315M
| $1.38M | ﹤0.01% |
87,891
+4,900
| +6% | +$77.7K |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.